Ziprasidone Hydrochloride Monohydrate

Ziprasidone (marketed as Geodon, Zeldox and Zipwell) was the fifth atypical antipsychotic to gain approval (February 2001) in the United States.

Catalog Number 10-101-129
Alternative Name(s) CP-88059, 5-(2-(4-(1,2-Benzisothiazol-3-yl)piperazinyl)ethyl)-6-chlorooxindole · HCl · H2O
Research Area Ziprasidone hydrochloride monohydrate is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia, acute mania and mixed states associated with bipolar disorder. Ziprasidone is also used off-label for depression, bipolar maintenance and PTSD.
Molecular Formula C21H21ClN4OS·ClH·H2O
CAS# 138982-67-9
Purity >95%
Size Inquiry
Supplier Page https://www.creative-peptides.com/product/ziprasidone-hydrochloride-monohydrate-item-10-101-129-122.html